NCT01104766 Safety and Efficacy of Cariprazine in Patients With Schizophrenia Status COMPLETED Phase PHASE3
NCT01101464 A Trial to Determine Whether Two Differing Strength Tablets (3 x 5 mg Versus 1 x 15 mg) of Sublingually Org 5222 (Asenapine) Are Safe and Equal in Subjects With Schizophrenia or Schizoaffective Disorder (P05937) Status COMPLETED Phase PHASE2
NCT01098110 6-week Trial of the Efficacy and Safety of Asenapine Compared to Placebo in Participants With an Acute Exacerbation of Schizophrenia (P06124) Status COMPLETED Phase PHASE3
NCT01094249 A Drug Interaction Study of Valproic Acid and Paliperidone Extended-Release (ER) in Patients With Schizophrenia, Bipolar I Disorder, or Schizoaffective Disorder Status COMPLETED Phase PHASE1
NCT01093365 Effect of Varenicline on Cognitive Function in Cigarette Smokers With Schizophrenia Status COMPLETED Phase PHASE2
NCT01092598 Factors Association With Poor Physical Function in Older Adults With Schizophrenia Status COMPLETED Phase N/A
NCT01091506 A Placebo-Controlled Study of Physiologic Effects of L-methylfolate in Schizophrenia Patients Status COMPLETED Phase NA
NCT01090440 Pharmacokinetics, Effect of Food, Safety and Tolerability of a New Tablet Formulation of GSK1144814 in Healthy Subjects Status COMPLETED Phase PHASE1
NCT01082588 Effects of Pravastatin on Cholesterol, Inflammation and Cognition in Schizophrenia Status COMPLETED Phase PHASE4
NCT01082250 The Bioequivalence Of Two Different Lurasidone Formulations In Patients Status COMPLETED Phase PHASE1
NCT01081769 Prevention of Relapse With Injectable Paliperidone Palmitate Versus Oral Antipsychotics Status COMPLETED Phase PHASE3
NCT01081418 Assertive Community Treatment (ACT) in Schizophrenia Spectrum Disorders Status COMPLETED Phase PHASE4
NCT01078870 Trial for Antidepressant Treatment for Negative Symptom of Schizophrenia With NRG1 Risk Genotype Status UNKNOWN Phase PHASE4